FloMedical’s Post

Exciting breakthrough in cancer detection! Researchers have enhanced blood tests, making it easier to detect circulating tumor DNA. This advancement could lead to earlier cancer diagnosis and more informed treatment decisions. Read more about this ground-breaking on MIT News: https://lnkd.in/gynUEwcJ #blood #bloodtest #healthcaretechnology #medicalinnovation #cancerdetection #biomedicalengineering

A new era in cancer detection is emerging. Our latest article explores how a drop of blood can now help predict the type of cancer you might develop and whether it could return. This advancement in liquid biopsy technology, led by IMBdx, is making cancer diagnosis and treatment more precise and accessible. Learn about the science behind this innovation and the impact it could have on the future of cancer care. #cancerdetection #cancerdignosis #bloodtest #genomeanalysis https://lnkd.in/gKHP-TaZ

"A high-tech double-barrel nanopipette, developed by University of Leeds scientists, and applied to the global medical challenge of cancer, has—for the first time—enabled researchers to see how individual living cancer cells react to treatment and change over time—providing vital understanding that could help doctors develop more effective cancer medication. Their findings are published in the journal Science Advances. The tool has two nanoscopic needles, meaning it can simultaneously inject and extract a sample from the same cell, expanding its potential uses. And the platform's high level of semi-automation has sped up the process dramatically, enabling scientists to extract data from many more individual cells, with far greater accuracy and efficiency than previously possible, the study shows." #cancer #oncology

Breast cancer is the most commonly diagnosed cancer (11.7%) and is a leading cause of cancer death (6.9%). Ductal carcinoma in situ (DCIS) accounts for about 25% of breast cancer diagnoses. Because it is difficult for clinicians to determine the type and stage of DCIS, patients with DCIS are often overtreated. An interdisciplinary team of researchers from the Massachusetts Institute of Technology and ETH Zürich developed an AI model that can identify the different stages of DCIS. Their model shows that both the state and arrangement of cells in a tissue sample are important for determining the stage of DCIS. The use of AI in healthcare surpasses expectations and makes a positive impact, from early disease detection to personalized treatment plans. AI can reduce the cost of healthcare and potentially save countless lives in the coming years. Paper: https://lnkd.in/emCjvv2u #artificialintelligence #ai #healthcare #machinelearning #mlmodel #mit

3D maps of cancer produced by an NIH initiative provide critical information on how tumors develop, spread, and respond to treatments. These maps provide a better understanding of the development and progression of cancer, which could eventually lead to new prevention and treatment strategies. #cancer #tumor #prevention

Researchers at the Paul Scherrer Institute (PSI) achieved an advance with the development of a test enabling early detection of cancer. The ability to detect a developing tumour at a very early stage and to closely monitor the success or failure of cancer therapy is crucial for a patient’s survival. A breakthrough on both counts has now been achieved by researchers at PSI. Using artificial intelligence (AI), the scientists were able to distinguish between healthy and sick people with about 85 percent accuracy. In addition, they managed to correctly determine the type of tumour disease – melanoma, glioma, or head and neck tumour, which is the first time anyone, worldwide, has achieved this. https://lnkd.in/e2tYTq8J #cancerresearch #artificialintelligence #seniorcare

Lung tumors called adenocarcinomas sometimes respond to initially effective treatments by transforming into a much more aggressive small cell lung cancer (SCLC) that spreads rapidly and has few options for treatment. Researchers have developed a mouse model that illuminates this problematic process, known as histological transformation. The findings advance the understanding of how mutated genes can trigger cancer evolution and suggest targets for more effective treatments. https://lnkd.in/dXjUF4nD #cancercare #articlewriting #cancer_types

How one type of lung cancer can transform into another . Lung tumors called adenocarcinomas sometimes respond to initially effective treatments by transforming into a much more aggressive small cell lung cancer (SCLC) that spreads rapidly and has few options for treatment. Researchers have developed a mouse model that illuminates this problematic process, known as histological transformation. The findings advance the understanding of how mutated genes can trigger cancer evolution and suggest targets for more effective treatments. #ScienceDailynews #InnovativeResearch #NextGenScience #ExploringFrontiers

What is the role of the TME in lung cancer evolution? - Charles Swanton American Association for Cancer Research The Francis Crick Institute Cancer Research UK (CRUK) https://lnkd.in/dXsdHmrA #Biomarkers #Cancer #CancerResearch #CD8 #LungCancer #Metastasis #MyeloidCells #BiomedicalResearch #NSCLC #OncoDaily #Oncology

Revolutionary Breakthrough in Brain Cancer Treatment: Discover Gladstone Institutes' pioneering "cancer shredding" technique utilizing CRISPR gene-editing technology. This groundbreaking approach offers new hope in battling primary glioblastoma, the deadliest brain cancer, by precisely targeting and eradicating recurring tumor cells.